TCMD Earnings Prediction
The chart below shows how TCMD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, TCMD sees a -0.81% change in stock price 10 days leading up to the earnings, and a +9.45% change 10 days following the report. On the earnings day itself, the stock moves by -1.35%. This data can give you a slight idea of what to expect for the next quarter's release.
TCMD Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
73.09M
5.04%
-0.17%
Gross Margin
74.96%
5.68%
2.64%
Operating Margin
9.28%
-19.16%
16.15%
Net Margin
7.05%
-78.00%
20.10%
EPS
0.21
-77.66%
16.67%
No Data Available
TCMD Earnings Analysis
Tactile Systems Technology, Inc. Corporation (TCMD.O) Earnings Conference Call
Positive
Third Quarter Revenue Increase: Total revenue in the third quarter increased $3.5 million or 5% to $73.1 million.
Lymphedema Product Sales Growth: By product line, sales and rentals of lymphedema products, which include our Flexitouch and Entre Systems, increased $2.8 million or 4% to $65.3 million and sales of our airway clearance products which include our AffloVest System, increased $0.7 million or 10% to $7.8 million.
Gross Margin Improvement: Gross margin was 75% of revenue compared to 70.9% in the third quarter of 2023.
Gross Margin Improvement: Non-GAAP gross margin, which excludes non-cash intangible amortization in both periods, was 75.4% compared to 71.4% in the prior year.
Revenue Growth Projection: We expect total revenue in the range of $292 million to $295 million, representing growth of approximately 6% to 8% year-over-year.
Negative
Third Quarter Revenue Increase: Total revenue in the third quarter increased $3.5 million or 5% to $73.1 million.
Lymphedema Product Sales Growth: Sales and rentals of lymphedema products, which include our Flexitouch and Entre Systems, increased $2.8 million or 4% to $65.3 million.
Airway Clearance Product Sales: Sales of our airway clearance products which include our AffloVest System, increased $0.7 million or 10% to $7.8 million.
Operating Expenses Increase: Third quarter operating expenses increased $6.6 million or 16% to $48 million.
Net Income Decline: Net income decreased $17.1 million to $5.2 million, or $0.21 per diluted share, compared to $22.3 million, or $0.94 per diluted share.
TCMD FAQs
How does TCMD typically perform around its earnings report dates?
Is Tactile Systems Technology, Inc. (TCMD) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
TCMD Earning Call Sentiment
Tactile Systems Technology, Inc. (TCMD) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
TCMD.O
-0.16%Positive
The earnings call presents a mixed outlook: while financial metrics like revenue growth and gross margin are positive, the company faces challenges such as Medicare documentation issues and uneven DME buying patterns. The revised guidance and impact on sales rep productivity are concerns. However, the share repurchase program and margin improvements are positives. The Q&A reveals management's confidence in stabilizing issues, but uncertainties remain, particularly around Medicare impacts and competitive pressures. Overall, the sentiment balances out to a neutral outlook.